Trade Mark Journal No.2026/038 18 September 2026

WO0000001936108 (1,5,42)

Office of origin: United States of America

Date of International Registration:24 June 2026
Date of designation in the UK: 24 June 2026
Image for mark 1936108 G-LINK

International priority date claimed: 30 December 2025 (United States of America) (99572088)
International priority date claimed: 23 June 2026 (United States of America) (99900744)
Class 1
Reagents for research purposes; reagents for medical research.
Class 5
Pharmaceuticals, namely, bio-pharmaceuticals for the treatment of genetic diseases and cancer; reagents for medical purposes; cellular pharmaceutical preparations for use in oncology and genetic diseases; pharmaceutical preparations for use in oncology.
Class 42
Research and development of bio-pharmaceuticals for the treatment of cancer and genetic diseases; medical and scientific research in the fields of genetics and oncology; development of therapeutics and cell therapies.

Vyriad, Inc.

Representative: Michelle L. Zimmermann Leydig, Voit & Mayer Ltd., 180 North Stetson Avenue, Suite 4900, Chicago IL 60601, UNITED STATES OF AMERICA